SCHEMBL9866047

SCHEMBL9866047

O=C(N/C(=N\CCCc1c[nH]cn1)NCCSc1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 4/20 0.43
HRH2 P25021 3/20 0.43
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
HRH1 P35367 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
RECQL P46063 1/20 0.41
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9865202 1.00 HRH4 (0.43) HRH4HRH2NPC1RAB9ASMN1; SMN2
SCHEMBL10369686 0.96 TDP1 (0.39) HRH4HRH2NPC1RAB9ASMN1; SMN2
SCHEMBL10369687 0.96 TDP1 (0.39) HRH4HRH2NPC1RAB9ASMN1; SMN2
SCHEMBL10369688 0.94 HRH4 (0.38) HRH4HRH2NPC1RAB9ASMN1; SMN2
SCHEMBL9866766 0.94 HRH2 (0.49) HRH4HRH2NPC1RAB9ASMN1; SMN2
SCHEMBL9865207 0.93 NPC1 (0.37) HRH4HRH2NPC1RAB9ASMN1; SMN2
SCHEMBL9865732 0.91 HPGD (0.52) HRH4HRH2NPC1RAB9ASMN1; SMN2
SCHEMBL9867694 0.89 HRH2 (0.44) HRH4HRH2NPC1RAB9ASMN1; SMN2
SCHEMBL9865910 0.88 KMT2A (0.43) HRH2NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL9866485 0.88 HRH4 (0.42) HRH4HRH2NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-B1 IMIDAZOLYLALKYLGUANIDIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HEUMANN PHARMA GMBH & CO (DE) 1990-08-01 EP disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 EP disclosed